200 related articles for article (PubMed ID: 32647009)
1. Direct relationship between increased expression and mistrafficking of the Charcot-Marie-Tooth-associated protein PMP22.
Marinko JT; Carter BD; Sanders CR
J Biol Chem; 2020 Aug; 295(34):11963-11970. PubMed ID: 32647009
[TBL] [Abstract][Full Text] [Related]
2. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
[TBL] [Abstract][Full Text] [Related]
3. Charcot-Marie-Tooth disease and related inherited neuropathies.
Murakami T; Garcia CA; Reiter LT; Lupski JR
Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of Charcot-Marie-Tooth 1A (CMT1A) neuropathy.
Hanemann CO; Müller HW
Trends Neurosci; 1998 Jul; 21(7):282-6. PubMed ID: 9683317
[TBL] [Abstract][Full Text] [Related]
5. Treating PMP22 gene duplication-related Charcot-Marie-Tooth disease: the past, the present and the future.
Boutary S; Echaniz-Laguna A; Adams D; Loisel-Duwattez J; Schumacher M; Massaad C; Massaad-Massade L
Transl Res; 2021 Jan; 227():100-111. PubMed ID: 32693030
[TBL] [Abstract][Full Text] [Related]
6. PMP22 expression in dermal nerve myelin from patients with CMT1A.
Katona I; Wu X; Feely SM; Sottile S; Siskind CE; Miller LJ; Shy ME; Li J
Brain; 2009 Jul; 132(Pt 7):1734-40. PubMed ID: 19447823
[TBL] [Abstract][Full Text] [Related]
7. Rer1 and calnexin regulate endoplasmic reticulum retention of a peripheral myelin protein 22 mutant that causes type 1A Charcot-Marie-Tooth disease.
Hara T; Hashimoto Y; Akuzawa T; Hirai R; Kobayashi H; Sato K
Sci Rep; 2014 Nov; 4():6992. PubMed ID: 25385046
[TBL] [Abstract][Full Text] [Related]
8. Peripheral myelin protein 22 modulates store-operated calcium channel activity, providing insights into Charcot-Marie-Tooth disease etiology.
Vanoye CG; Sakakura M; Follis RM; Trevisan AJ; Narayan M; Li J; Sanders CR; Carter BD
J Biol Chem; 2019 Aug; 294(32):12054-12065. PubMed ID: 31213528
[TBL] [Abstract][Full Text] [Related]
9. Schwann cell transcript biomarkers for hereditary neuropathy skin biopsies.
Svaren J; Moran JJ; Wu X; Zuccarino R; Bacon C; Bai Y; Ramesh R; Gutmann L; Anderson DM; Pavelec D; Shy ME
Ann Neurol; 2019 Jun; 85(6):887-898. PubMed ID: 30945774
[TBL] [Abstract][Full Text] [Related]
10. Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs.
Hanemann CO; Gabreëls-Festen AA; Stoll G; Müller HW
Acta Neuropathol; 1997 Oct; 94(4):310-5. PubMed ID: 9341930
[TBL] [Abstract][Full Text] [Related]
11. Inherited demyelinating neuropathies with micromutations of peripheral myelin protein 22 gene.
Taioli F; Cabrini I; Cavallaro T; Acler M; Fabrizi GM
Brain; 2011 Feb; 134(Pt 2):608-17. PubMed ID: 21252112
[TBL] [Abstract][Full Text] [Related]
12. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease.
Nobbio L; Vigo T; Abbruzzese M; Levi G; Brancolini C; Mantero S; Grandis M; Benedetti L; Mancardi G; Schenone A
Neurobiol Dis; 2004 Jun; 16(1):263-73. PubMed ID: 15207283
[TBL] [Abstract][Full Text] [Related]
13. Elevated Peripheral Myelin Protein 22, Reduced Mitotic Potential, and Proteasome Impairment in Dermal Fibroblasts from Charcot-Marie-Tooth Disease Type 1A Patients.
Lee S; Bazick H; Chittoor-Vinod V; Al Salihi MO; Xia G; Notterpek L
Am J Pathol; 2018 Mar; 188(3):728-738. PubMed ID: 29246495
[TBL] [Abstract][Full Text] [Related]
14. How T118M peripheral myelin protein 22 predisposes humans to Charcot-Marie-Tooth disease.
Stefanski KM; Li GC; Marinko JT; Carter BD; Samuels DC; Sanders CR
J Biol Chem; 2023 Feb; 299(2):102839. PubMed ID: 36581210
[TBL] [Abstract][Full Text] [Related]
15. Gene dosage effects in hereditary peripheral neuropathy. Expression of peripheral myelin protein 22 in Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies nerve biopsies.
Gabriel JM; Erne B; Pareyson D; Sghirlanzoni A; Taroni F; Steck AJ
Neurology; 1997 Dec; 49(6):1635-40. PubMed ID: 9409359
[TBL] [Abstract][Full Text] [Related]
16. Inducible HSP70 is critical in preventing the aggregation and enhancing the processing of PMP22.
Chittoor-Vinod VG; Lee S; Judge SM; Notterpek L
ASN Neuro; 2015; 7(1):. PubMed ID: 25694550
[TBL] [Abstract][Full Text] [Related]
17. PMP22 overexpression causes dysmyelination in mice.
Robaglia-Schlupp A; Pizant J; Norreel JC; Passage E; Sabéran-Djoneidi D; Ansaldi JL; Vinay L; Figarella-Branger D; Lévy N; Clarac F; Cau P; Pellissier JF; Fontés M
Brain; 2002 Oct; 125(Pt 10):2213-21. PubMed ID: 12244079
[TBL] [Abstract][Full Text] [Related]
18. Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy.
Chumakov I; Milet A; Cholet N; Primas G; Boucard A; Pereira Y; Graudens E; Mandel J; Laffaire J; Foucquier J; Glibert F; Bertrand V; Nave KA; Sereda MW; Vial E; Guedj M; Hajj R; Nabirotchkin S; Cohen D
Orphanet J Rare Dis; 2014 Dec; 9():201. PubMed ID: 25491744
[TBL] [Abstract][Full Text] [Related]
19. Electroceutical approach ameliorates intracellular PMP22 aggregation and promotes pro-myelinating pathways in a CMT1A in vitro model.
Intisar A; Woo H; Kang HG; Kim WH; Shin HY; Kim MY; Kim YS; Mo YJ; Lee YI; Kim MS
Biosens Bioelectron; 2023 Mar; 224():115055. PubMed ID: 36630746
[TBL] [Abstract][Full Text] [Related]
20. Targeted PMP22 TATA-box editing by CRISPR/Cas9 reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice.
Lee JS; Lee JY; Song DW; Bae HS; Doo HM; Yu HS; Lee KJ; Kim HK; Hwang H; Kwak G; Kim D; Kim S; Hong YB; Lee JM; Choi BO
Nucleic Acids Res; 2020 Jan; 48(1):130-140. PubMed ID: 31713617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
